FDA Investigator Samantha J Pinizzotto, D V M

Samantha J Pinizzotto, D V M has inspections in 5 countries as of 03 Nov 2023. Samantha J Pinizzotto, D V M has collaborated with a combinined 3346 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
262
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100005935
Country:
United States of America, Canada, India, Netherlands, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Aaron J Fox, Albert A Salvador, Amanda B Vega, Amy Kim, Angela E Glenn, Annette Melendez, Anthony J Grace, Arindam Dasgupta, PhD, Ashley B Jelonek, Audrey J Yarbrough, Barbara A Rusin, Barbara G Peoples, Barbara M Frazier, Barbara T Carmichael, Bill Tacket, Jr, Bonita S Chester, Bora Veliu, Brandy D Brown, Brentley S Collins, Camilla S Smith, Carla J Lundi, Carol F Robinson, Carol S Davis, CDR Rochelle B Young, RPh, MSA, Charles D Boison, Cheryl A Clausen, Christie A Soto, Christopher J Adams, Christos G Tsingelis, Claire M Minden, Cody D Rickman, Colleen M Aspinwall, Cordelia J Brammer, Courtney A Gilbert, Craig A Garmendia, Cynthia L Medlin, Daniel L Aisen, Danielle M Maddox, Darcy L Webber, Daryl A Dewoskin, David P King, Debra D Devlieger, Dianiris C Ayala, Dillard H Woody, Jr, Dipesh K Shah, Donald M Mack, Donna D Gallien, MPH, Doretha M Wilson, Douglas L Page, Edward A Brunt, Edwards, Edwin J Gorney, Emily E Smith, Ernest A Clausnitzer, Ethan P Stegman, Gajendiran Mahadevan, PhD, Gamal A Norton, Gene D Arcy, Gene R Gunn, George C Amedro, George J Flynn, Geraldine D Sanders, Gerardo Z Vazquez, German Rivera, Glenn S Quintanilla, Holly M Scott, Howard A Webley, Hunt, Ivan E Reyes, Jana L Caylor, Jane E Nelson, Jason P Aun, Jean A Peeples, Jennifer A Robinson, Jennifer L Sheehan, Joan A Loreng, Joanne M Schlossin, John A Kadavil, PhD, Johnathan M Crayton, Jolanna A Norton, Jose R Rodriguez, Joshua J Silvestri, Judy Ellen Ciaraldi, Kanaeko R Raverell, Karen M Cooper, Karl D Hezel, Katherine Szestypalow, Kayla V Sprague, Keith A Schwartz, Kelly I Anderson, Kenneth R Merritt, Kip J Hanks, Konsuela Y Glass, Ladislav Kermet, Laressa R Gray, Larry K Austin, Laura B Kennedy, Laura E Garcia, Laura M Lopez, Lawrence A Butler, Lawrence Y Lee, PhD, LCDR Michael H Tollon, LCDR Randall L Morris, Leo J Lagrotte, Leon L Crawley, Leon L Law, Leslie A Cartmill, Leslie A Jackanicz, Li Hongpaul Yeh, PhD, Linda K Matheny, Lindsay R Hatch, Lindsay R Mundy, Lisa A Warner, Lisa P Oakes, Lizaida E Rodriguez, LT Daveta L Bailey, LT Prince D Brown, Lundy H Patrick, Lura D Baquero, Lura D Kelly, Madelyn Renteria, Martin K Yau, PhD, Marybeth Willis, Matthew B Thomaston, Megan K Otero, Melanie G Warzala, Melanie W Pishnery, Melinda B Lewis, Melkamu Getie Kebtie, PhD, Michael D Gifford, Miguel A Martinez, Mizanne E Lewis, Mohsen Rajabi Abhari, FDA, Monica Cburgos Garcia, Myra K Casey, Nancy A Bellamy, Nancy L Meade, Nancy L Neiger, Nicola M Fenty Stewart, Nicolas Riveratorres, Nicole E Knowlton, Norton, Ormond, Patrick D Stone, MS, Paul A Licata, Paul L Figarole, Jr, Paula M Laplant, Peter R Lenahan, Randy L Clarida, Raymond A Lyn, Jr, Reynolds, Richard J Bashay, Richard K Vogel, Robert E Hultman, Robert L Lewis, Jr, Robert W Calais, Rodney W Lenger, Ronda R Loyd, Ronda R Loyd Jones, Ronnie E Jackson, Rosia E Nesbitt, Salvatore N Randazzo, Sam H Haidar, PhD, Samantha J Finizzotto, Scott B Laufenberg, Seongeun Cho (Julia), PhD, Sergio E Delgado, Shavon L Square, Sripal R Mada, PhD, Stacey F Rivette, Stanley B Eugene, BS, BME, State Agency, Steven A Brettler, Susan D Yuscius, Terri E Gibson, Thai D Truong, Theressa B Smith, Thomas J Hudson, Thomas W Nojek, Traci M Armand, Tracy L Reed, Travis M Beard, Travis S Bradley, Valerie J Grecek Trinh, Verdell Nelson, Vickie J Kanion, Victor Spanioli, Whitney M White, Woody

Samantha J Pinizzotto, D V M's Documents

Publish Date Document Type Title
November, 2016 EIR OneBlood, Inc. - EIR, 2016-11-01
February, 2020 FDA 483 SGF Tampa Bay LLC - Form 483, 2020-02-24
June, 2012 FDA 483 Cox Seafood-Tarpon Springs, Inc. - Form 483, 2012-06-01
June, 2023 FDA 483 Regenerative Processing Plant, LLC - Form 483, 2023-06-30
June, 2011 FDA 483 Dr. Gigi C. Lefebvre - Form 483, 2011-06-15
December, 2015 EIR Vivex Biologics, Inc. - EIR, 2015-12-18
June, 2011 FDA 483 Ion Labs Inc - Form 483, 2011-06-03
August, 2015 EIR Regenerative Processing Plant, LLC - EIR, 2015-08-31
February, 2018 EIR Cryo-Cell International, Inc - EIR, 2018-02-06
August, 2017 EIR Regenerative Processing Plant, LLC - EIR, 2017-08-14
April, 2013 EIR Alberto A. Chiappori, M.D. - EIR, 2013-04-05
November, 2016 FDA 483 OneBlood, Inc. - Form 483, 2016-11-01
June, 2023 FDA 483 Regenerative Processing Plant, LLC - Form 483, 2023-06-23
April, 2013 FDA 483 Scott J. Antonia, M.D. - Form 483, 2013-04-05
June, 2013 FDA 483 QPS Bioserve India Private Limited - Form 483, 2013-06-21
June, 2022 FDA 483 Denker, Mark S, MD PA - Form 483, 2022-06-06
July, 2009 FDA 483 Biolife, LLC - Form 483, 2009-07-31
December, 2019 EIR Regenerative Processing Plant, LLC - EIR, 2019-12-12
August, 2012 FDA 483 Syneos Health Clinique Inc - Form 483, 2012-08-10
July, 2019 FDA 483 The Reproductive Medicine Group, LLC - Form 483, 2019-07-31
February, 2023 FDA 483 Florida Fertility Institute, P.A. - Form 483, 2023-02-02
August, 2010 FDA 483 Abba Pharma, Inc - Form 483, 2010-08-30
March, 2016 EIR Creative Testing Solutions - EIR, 2016-03-17
July, 2019 EIR The Reproductive Medicine Group, LLC - EIR, 2019-07-12
May, 2023 FDA 483 Safari Stem Cell, LLC - Form 483, 2023-05-04
July, 2019 FDA 483 RMG ART Laboratories, LLC - Form 483, 2019-07-12
December, 2015 FDA 483 Vivex Biologics, Inc. - Form 483, 2015-12-18

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more